Skip to content
Inciteful Med

The Three Pillars: Standard of Care Treatment for OI

Last updated:

The standard of care for Osteogenesis Imperfecta (OI) involves three main pillars: bisphosphonate medications to increase bone density, intramedullary rodding surgeries to stabilize bowing bones, and physical therapy to build protective muscle strength and maximize mobility.

Key Takeaways

  • • Bisphosphonates are the gold standard medical treatment used to increase bone density and reduce bone pain in children with OI.
  • • Intramedullary rodding surgeries, such as the use of telescopic rods, provide internal scaffolding to correct bowed bones and prevent repeated fractures.
  • • Physical and occupational therapy are critical for building muscle strength, which naturally protects fragile bones from breaking.
  • • Aquatic therapy is highly recommended for OI patients because water buoyancy allows for safe movement and strengthening without full gravitational weight.
  • • Emerging treatments currently in clinical trials include bone-building anabolic agents and experimental gene editing therapies.

Managing Osteogenesis Imperfecta (OI) requires more than just fixing broken bones. It requires a multidisciplinary approach—a team of specialists working together to strengthen the bones, stabilize the skeleton, and maximize mobility [1][2].

While there is currently no cure for the underlying collagen defect, the current Standard of Care has significantly improved the quality of life and independence for people with OI [3][4].

Medical Management: Strengthening the Matrix

The gold standard for medical treatment in pediatric OI is the use of bisphosphonates [5][2]. These medications, such as pamidronate or zoledronic acid, are typically given through an IV infusion [5][6].

  • How They Work: Bisphosphonates inhibit osteoclasts, the cells that break down bone. By slowing this process, the body has more time to build up bone mineral, which increases overall bone density and can reduce bone pain [5][7].
  • The Limitation: It is important to remember that these drugs do not “fix” the malformed collagen; they simply add more mineral to the existing “scaffolding” [5][8].
  • Side Effects: Common side effects can include temporary flu-like symptoms after the first infusion. Long-term use requires careful monitoring for potential rare complications like delayed tooth eruption or Osteonecrosis of the Jaw (ONJ). While ONJ is exceedingly rare in children, dentists will be highly vigilant about this if your child is on bisphosphonates [9][10].

Surgical Management: Internal Scaffolding

When bones are severely bowed or fracture repeatedly, surgeons use intramedullary rodding to provide internal support [11][3].

  • Telescopic Rods: In growing children, the “gold standard” for leg bones is the telescopic rod (such as the Fassier-Duval™ system) [12][13]. These rods are designed to “elongate” as the bone grows, which helps reduce the number of surgeries a child needs over time [12][14].
  • Static Rods: While telescopic rods are ideal for growing leg bones, older “static” (non-growing) rods like Rush pins or K-wires remain a vital and appropriate standard of care for specific situations. They are widely used for smaller bones (like the forearm), in bones with canals too narrow for telescopic rods, or in very young infants [11][13].
  • Benefits: Successful rodding can correct “bowing” deformities, stabilize the limb, and significantly improve a child’s ability to stand or walk [15][14].

Rehabilitation: The Power of Muscle

Physical therapy (PT) and occupational therapy (OT) are just as critical as surgery or medication [4][16].

  • Muscle Protects Bone: Strong muscles act as natural “splints” that help protect fragile bones from breaking [17][18].
  • Safe Handling: For infants and young children, therapists teach parents “safe handling” techniques for bathing, dressing, and diapering to prevent accidental fractures [1][19].
  • Aquatic Therapy: Swimming or water exercises are often highly recommended because the water’s buoyancy allows children to move and strengthen muscles without the full weight of gravity on their bones [4][20].

The Future: Emerging Therapies

While bisphosphonates are the current standard, researchers are investigating new treatments that work in different ways [8][21].

  • Anabolic Agents: Medications like setrusumab (an anti-sclerostin antibody) are designed to actively “build” new bone rather than just stopping bone breakdown. These are currently in clinical trials [8][22].
  • Gene Therapy: Scientists are exploring ways to “silence” the mutated gene or “edit” the DNA using tools like CRISPR. However, these therapies are still in early experimental stages and are not yet part of standard clinical care [8][23].

By combining these three pillars—medication, surgery, and rehabilitation—the goal of the standard of care is to empower every child with OI to reach their full potential for mobility and independence [24][1].

Frequently Asked Questions

How do bisphosphonate medications treat Osteogenesis Imperfecta?
Bisphosphonates work by inhibiting osteoclasts, which are the cells responsible for breaking down bone. By slowing this process, the body has more time to build up bone mineral, increasing overall bone density and reducing bone pain.
What is the difference between telescopic and static rods for OI surgery?
Telescopic rods are designed to elongate as a child's bone grows, which helps minimize the number of future surgeries needed. Static rods do not expand but remain a vital option for smaller bones, narrow bone canals, or very young infants.
Why is physical therapy important for a child with OI?
Physical therapy helps build strong muscles that act as natural splints, protecting fragile bones from breaking. Therapists also teach parents safe handling techniques for bathing and dressing to prevent accidental fractures in infants.
Are there any new or experimental treatments for Osteogenesis Imperfecta?
While bisphosphonates are the current standard, researchers are testing anabolic agents like setrusumab that actively build new bone. Scientists are also exploring early-stage gene therapies designed to address the underlying collagen mutation.

Questions for Your Doctor

  • • Which bisphosphonate do you recommend for my child—pamidronate or zoledronic acid—and what is the specific infusion schedule?
  • • Is my child a candidate for telescopic rods, and what specific brand (like the Fassier-Duval) do you have the most experience with?
  • • How do we know when my child is 'outgrowing' their current rods, and what signs of hardware failure should we watch for?
  • • Can you refer us to a physical therapist who has specifically treated children with OI?
  • • If my child's response to bisphosphonates is not sufficient, are there any clinical trials for newer medications (like setrusumab) that we should consider?

Questions for You

  • • How do we feel about the transition from 'protecting' our child from fractures to 'encouraging' movement through physical therapy?
  • • What is our family's plan for managing the travel and time required for regular infusion appointments or specialized surgeries?
  • • How can we best document our child's surgical and medication history to ensure all future providers understand their 'standard of care' baseline?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Adapting to Adulthood: A Review of Transition Strategies for Osteogenesis Imperfecta.

    Celli L, Garrelfs MR, Sakkers RJB, et al.

    Calcified tissue international 2024; (115(6)):960-975 doi:10.1007/s00223-024-01305-1.

    PMID: 39535563
  2. 2

    [Rehabilitation of orphan diseases in adulthood: osteogenesis imperfecta].

    Gehlen M, Schwarz-Eywill M, Hinz C, et al.

    Zeitschrift fur Rheumatologie 2021; (80(1)):29-42 doi:10.1007/s00393-020-00927-8.

    PMID: 33259008
  3. 3

    A Fracture From a Physical Exam: A Case Report of Osteogenesis Imperfecta and the Use of Fassier-Duval Rods.

    Rella RT, Brandon AS, Garrison IA, et al.

    Cureus 2023; (15(4)):e37068 doi:10.7759/cureus.37068.

    PMID: 37153255
  4. 4

    Effect of physiotherapy rehabilitation on osteogenesis imperfecta with a midshaft tibial fracture in the 11-year-old patient: a case report.

    Nangliya RM, Jain DS, Saklecha AV, Patil DS

    The Pan African medical journal 2022; (43()):201 doi:10.11604/pamj.2022.43.201.34702.

    PMID: 36942134
  5. 5

    Optimizing bone health with bisphosphonate therapies in pediatric osteogenesis imperfecta: a network meta-analysis of randomized trials.

    Wang YY, Su YC, Lai PC, et al.

    Archives of osteoporosis 2025; (20(1)):33 doi:10.1007/s11657-025-01515-6.

    PMID: 40047985
  6. 6

    A Systematic Review on the Efficacy of Bisphosphonates on Osteogenesis Imperfecta.

    Datir RR, Datir RR, Datir PR, Heyrani N

    Cureus 2025; (17(6)):e86549 doi:10.7759/cureus.86549.

    PMID: 40698241
  7. 7

    Treatment response to long term antiresorptive therapy in osteogenesis imperfecta type VI: does genotype matter?

    Celik NB, Gonc N, Ozon A, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2020; (33(12)):1617-1624 doi:10.1515/jpem-2020-0260.

    PMID: 33031053
  8. 8

    Current and Developing Pharmacologic Agents for Improving Skeletal Health in Adults with Osteogenesis Imperfecta.

    Liu W, Nicol L, Orwoll E

    Calcified tissue international 2024; (115(6)):805-811 doi:10.1007/s00223-024-01188-2.

    PMID: 38472351
  9. 9

    Safety and Efficacy of Zoledronic Acid in children with Osteogenesis Imperfecta.

    Riaz M, Hafeez S, Ibrahim MN, et al.

    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 2022; (32(9)):1165-1169 doi:10.29271/jcpsp.2022.09.1165.

    PMID: 36089714
  10. 10

    Influence of zoledronic acid and pamidronate on tooth eruption in children with osteogenesis imperfecta.

    Del Rio Cantero N, Mourelle Martínez MR, Sagastizabal Cardelús B, De Nova García JM

    Bone 2024; (182()):117069 doi:10.1016/j.bone.2024.117069.

    PMID: 38458305
  11. 11

    Telescopic rodding in children: Technical progression from Dubow-Bailey to Fassier-Duval™.

    Fassier A

    Orthopaedics & traumatology, surgery & research : OTSR 2021; (107(1S)):102759 doi:10.1016/j.otsr.2020.102759.

    PMID: 33316440
  12. 12

    Plates for the treatment of long bone metaphyseal and diaphyseal fracture and deformity in osteogenesis imperfecta: A scoping review.

    Louni Y, Hamdy R

    Journal of children's orthopaedics 2025; (19(3)):199-206 doi:10.1177/18632521251332498.

    PMID: 40292352
  13. 13

    Complications of Elongating Intramedullary Rods in the Treatment of Lower Extremity Fractures for Osteogenesis Imperfecta: A Meta-Analysis of 594 Patients in 40 Years.

    Yong B, De Wouters S, Howard A

    Journal of pediatric orthopedics 2022; (42(3)):e301-e308 doi:10.1097/BPO.0000000000002040.

    PMID: 35034037
  14. 14

    Extendable intramedullary nailing in a child with osteogenesis imperfecta of bilateral femoral fractures: a case report.

    Zhang W, Lu X, Yang N, et al.

    Frontiers in surgery 2025; (12()):1454192 doi:10.3389/fsurg.2025.1454192.

    PMID: 41607377
  15. 15

    Clinical and Functional Outcomes of Telescoping Intramedullary Nails in Pediatric Osteogenesis Imperfecta: A Multicenter Prospective Study With a One-Year Follow-Up.

    Tayyab M, Saqib M, Tanveer M, et al.

    Cureus 2025; (17(8)):e90656 doi:10.7759/cureus.90656.

    PMID: 40978980
  16. 16

    Curative Cell and Gene Therapy for Osteogenesis Imperfecta.

    Schindeler A, Lee LR, O'Donohue AK, et al.

    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2022; (37(5)):826-836 doi:10.1002/jbmr.4549.

    PMID: 35306687
  17. 17

    Physiological Loading-Induced Interstitial Fluid Dynamics in Osteon of Osteogenesis Imperfecta Bone.

    Shrivas NV, Tiwari AK, Kumar R, et al.

    Journal of biomechanical engineering 2021; (143(8)) doi:10.1115/1.4050818.

    PMID: 33834233
  18. 18

    Recent developments in osteogenesis imperfecta.

    Shaker JL, Albert C, Fritz J, Harris G

    F1000Research 2015; (4(F1000 Faculty Rev)):681 doi:10.12688/f1000research.6398.1.

    PMID: 26401268
  19. 19

    Oral health-related quality of life in children and adolescents with osteogenesis imperfecta: cross-sectional study.

    Najirad M, Ma MS, Rauch F, et al.

    Orphanet journal of rare diseases 2018; (13(1)):187 doi:10.1186/s13023-018-0935-y.

    PMID: 30359278
  20. 20

    Comprehensive Review of Osteogenesis Imperfecta: Current Treatments and Future Innovations.

    Chaugule S, Constantinou CK, John AA, et al.

    Human gene therapy 2025; (36(5-6)):597-617 doi:10.1089/hum.2024.191.

    PMID: 39932815
  21. 21

    Approach to the Patient: Pharmacological Therapies for Fracture Risk Reduction in Adults With Osteogenesis Imperfecta.

    Liu W, Lee B, Nagamani SCS, et al.

    The Journal of clinical endocrinology and metabolism 2023; (108(7)):1787-1796 doi:10.1210/clinem/dgad035.

    PMID: 36658750
  22. 22

    Enhancing Wnt signaling lowers fracture incidence in a severe mouse model of Osteogenesis Imperfecta.

    Montagna G, Lee S, Baacke A, et al.

    bioRxiv : the preprint server for biology 2025; doi:10.1101/2025.05.27.656429.

    PMID: 40501669
  23. 23

    Osteoblasts mineralization and collagen matrix are conserved upon specific Col1a2 silencing.

    Maruelli S, Besio R, Rousseau J, et al.

    Matrix biology plus 2020; (6-7()):100028 doi:10.1016/j.mbplus.2020.100028.

    PMID: 33543025
  24. 24

    Osteogenesis imperfecta: exploring an autoimmune and immunotherapy perspective.

    Goddard JF, Mehrotra S, Mehrotra M

    JBMR plus 2025; (9(6)):ziaf053 doi:10.1093/jbmrpl/ziaf053.

    PMID: 40353205

This page explains standard treatment options for Osteogenesis Imperfecta for educational purposes only. Always consult your pediatric orthopedist and medical team before making decisions about medications, surgeries, or physical therapy.

Stay up to date

Get notified when new research about Osteogenesis imperfecta is published.

No spam. Unsubscribe anytime.